Spots Global Cancer Trial Database for gastroesophageal carcinoma
Every month we try and update this database with for gastroesophageal carcinoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Pralatrexate and Docetaxel in Treating Patients With Stage IV Esophageal or Gastroesophageal Cancer Who Have Failed Platinum-Based Therapy | NCT01129206 | Adenocarcinoma ... Adenocarcinomas... Recurrent Esoph... Squamous Cell C... Stage IV Esopha... | pralatrexate docetaxel fludeoxyglucose... positron emissi... | 18 Years - | Ohio State University Comprehensive Cancer Center | |
Pralatrexate and Docetaxel in Treating Patients With Stage IV Esophageal or Gastroesophageal Cancer Who Have Failed Platinum-Based Therapy | NCT01129206 | Adenocarcinoma ... Adenocarcinomas... Recurrent Esoph... Squamous Cell C... Stage IV Esopha... | pralatrexate docetaxel fludeoxyglucose... positron emissi... | 18 Years - | Ohio State University Comprehensive Cancer Center |